Expression and roles of fatty acid synthase in hepatocellular carcinoma

Oncology Reports

Volumn 32, Issue 6, 2014, Pages 2471-2476

  Hao, Qiwei ^a   Li, Tao ^a   Zhang, Xiong ^a   Gao, Ping ^a   Qiao, Peiyu ^a   Li, Sheng ^a   Geng, Zhimin ^b  

^a Second Hospital of Yulin City   (China)

^b THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Fatty acid synthase; Hepatocellular carcinoma; Invasion; Proliferation; RNA interference

Indexed keywords

FATTY ACID SYNTHASE; SHORT HAIRPIN RNA; FASN PROTEIN, HUMAN;

ARTICLE; CANCER GROWTH; CANCER TISSUE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EXPRESSION VECTOR; FASN GENE; FEMALE; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CANCER CELL LINE; LIVER CELL; LIVER CELL CARCINOMA; MALE; METASTASIS POTENTIAL; ONCOGENE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TISSUE DISTRIBUTION; TUMOR INVASION; WESTERN BLOTTING; APOPTOSIS; CELL MOTION; ENZYMOLOGY; GENE EXPRESSION; GENETICS; LIVER TUMOR; METABOLISM; TUMOR CELL LINE;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FATTY ACID SYNTHASE, TYPE I; FEMALE; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HUMANS; LIVER NEOPLASMS; MALE;

EID: 84914684781     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3484     Document Type: Article

References (18)

1. Daker M, Bhuvanendran S, Ahmad M, Takada K and Khoo AS: Deregulation of lipid metabolism pathway genes in nasopharyngeal carcinoma cells. Mol Med Rep 7: 731-741, 2013.
2. Grunt TW, Wagner R, Grusch M, et al: Interaction between fatty acid synthase- and ErbB-systems in ovarian cancer cells. Biochem Biophys Res Commun 385: 454-459, 2009.
3. Zhou Y, Niu C, Li Y, et al: Fatty acid synthase expression and esophageal cancer. Mol Biol Rep 39: 9733-9739, 2012.
4. Cerne D, Zitnik IP and Sok M: Increased fatty acid synthase activity in non-small cell lung cancer tissue is a weaker predictor of shorter patient survival than increased lipoprotein lipase activity. Arch Med Res 41: 405-409, 2010.
5. Cairns RA, Harris I, McCracken S and Mak TW: Cancer cell metabolism. Cold Spring Harb Symp Quant Biol 76: 299-311, 2011.
6. Glaysher J: Lipid metabolism and cancer. Curr Opin Lipidol 24: 530-531, 2013.
7. Kuhajda FP: Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition 16: 202-208, 2000.
8. Pflug BR, Pecher SM, Brink AW, Nelson JB and Foster BA: Increased fatty acid synthase expression and activity during progression of prostate cancer in the TRAMP model. Prostate 57: 245-254, 2003.
9. Swinnen JV, Roskams T, Joniau S, et al: Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer. Int J Cancer 98: 19-22, 2002.
10. Horiguchi A, Asano T, Asano T, Ito K, Sumitomo M and Hayakawa M: Fatty acid synthase over expression is an indicator of tumor aggressiveness and poor prognosis in renal cell carcinoma. J Urol 180: 1137-1140, 2008.
11. Sugino T, Baba K, Hoshi N, Aikawa K, Yamaquchi O and Suzuki T: Overexpression of fatty acid synthase in human urinary bladder cancer and combined expression of the synthase and Ki-67 as a predictor of prognosis of cancer patients. Med Mol Morphol 44: 146-150, 2011.
12. Pizer ES, Kurman RJ, Pasternack GR and Kuhajda FP: Expression of fatty acid synthase is closely linked to proliferation and stromal decidualization in cycling endometrium. Int J Gynecol Pathol 16: 45-51, 1997.
13. Liu ZL, Zhou Y, Luo QF, et al: Inhibition of fatty acid synthase supresses osteosarcoma cell invasion and migration. Indian J Pathol Microbiol 55: 163-169, 2012.
14. Long XH, Mao JH, Peng AF, Zhou Y, Huang SH and Liu ZL: Tumor suppressive microRNA-424 inhibits osteosarcoma cell migration and invasion via targeting fatty acid synthase. Exp Ther Med 5: 1048-1052, 2013.
15. Alli PM, Pinn ML, Jaffee EM, McFadden JM and Kuhajda FP: Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice. Oncogene 24: 39-46, 2005.
16. Menendez JA, Mehmi I, Verma VA, Teng PK and Lupu R: Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation. Mol Carcinog 41: 164-178, 2004.
17. Pandey PR, Liu W, Xing F, Fukuda K and Watabe K: Anti-cancer drugs targeting fatty acid synthase (FAS). Recent Pat Anticancer Drug Discov 7: 185-197, 2012.
18. Calvisi DF, Wang C, Ho C, et al: Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma. Gastroenterology 140: 1071-1083, 2011.